Загрузка...
Cost-effectiveness analysis of rifaximin-α administration for the reduction of episodes of overt hepatic encephalopathy in recurrence compared with standard treatment in France
BACKGROUND: Hepatic encephalopathy (HE) is a complex neuropsychiatric syndrome that occurs most often in a context of acute or chronic liver disease. Despite the seriousness of the pathology, only a few treatments have been developed for improving its management. Rifaximin-α is the first treatment t...
Сохранить в:
| Опубликовано в: : | Therap Adv Gastroenterol |
|---|---|
| Главные авторы: | , , , , |
| Формат: | Artigo |
| Язык: | Inglês |
| Опубликовано: |
SAGE Publications
2016
|
| Предметы: | |
| Online-ссылка: | https://ncbi.nlm.nih.gov/pmc/articles/PMC4913340/ https://ncbi.nlm.nih.gov/pubmed/27366216 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1177/1756283X16644249 |
| Метки: |
Добавить метку
Нет меток, Требуется 1-ая метка записи!
|